| Mylan Pharma GmbH - Influvac, Injektionssuspension | | 00485 | | 29 | | Influvac | | Injektionssuspension | | J07BB02 | | Influenza, gereinigtes Antigen | | 21.07.2016 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) (Virus-Stamm A/California/7/2009 (H1N1)-like: reassortant virus NYMC X-181) 15 µg, haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Hong Kong/4801/2014 (H3N2)-like: reassortant virus NYMC X-263B) 15 µg, haemagglutininum influenzae B (Virus-Stamm B/Brisbane/60/2008) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, residui: ovalbuminum max. 0.1 µg, formaldehydum et cetrimidum et polysorbatum 80 et gentamicinum nihil, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. | | Packungsbestandteile | | Suspension injectable | | | | | | Principe actif | Concentr. |
|---|
| Haemagglutininum Influenzae a (H1N1) (Virus-Stamm A/california/7/2009 (H1N1)-Like: Reassortant Virus nymc X-181) | 15 µg | | Haemagglutininum Influenzae a (H3N2) (Virus-Stamm A/hong Kong/4801/2014 (H3N2)-Like: Reassortant Virus nymc X-263b) | 15 µg | | Haemagglutininum Influenzae b (Virus-Stamm B/brisbane/60/2008) | 15 µg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Calcium Chlorure | | | | Cetrimide | | | | Disodium Phosphate Dihydrate | | | | Formaldehydum | | | | Gentamicinum Nihil | | | | Potassium Chlorure | | | | Potassium Dihydrogenophosphate | | | | Magnesium Chloride Hexahydrate | | | | Sodium Chlorure | | | | Ovalbuminum | 0.1 µg | residui | | Polysorbatum 80 | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| Aucune entrée n'a été trouvée. |
|
|
